Moderna Therapeutics

ASCO in Review: Oncologists See Practice-Changing, Affirming Data
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
Flag link:
BIO: Moderna to test mpox vaccine in humans this summer
BIO: Moderna to test mpox vaccine in humans this summer
Fierce Biotech
BIO 2023
Moderna Therapeutics
mpox
vaccines
Flag link:
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Yahoo/Reuters
ASCO 2023
Merck
Moderna Therapeutics
MRNA
vaccines
skin cancer
Flag link:
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Fierce Pharma
Alnylam Pharmaceuticals
legal
patents
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Flag link:
Moderna looks for opportunities in China after registering legal entity
Moderna looks for opportunities in China after registering legal entity
Reuters
Moderna Therapeutics
China
Flag link:
Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far
Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far
Fierce Biotech
ReNAgade Therapeutics
RNA
Moderna Therapeutics
funding
Flag link:
Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test
Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test
Fierce Biotech
Moderna Therapeutics
MRNA
intracellular proteins
clinical trials
propionic acidemia
Flag link:
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%
Motley Fool
Moderna Therapeutics
earnings
Flag link:
Moderna hits back at Alnylam's 'baseless' patent infringement claims
Moderna hits back at Alnylam's 'baseless' patent infringement claims
Fierce Pharma
Moderna Therapeutics
Alnylam
MRNA
vaccines
legals
Flag link:
A blockbuster year could be building
A blockbuster year could be building
EP Vantage
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
Flag link:
Revenues down for Moderna, up for Regeneron in Q1
Revenues down for Moderna, up for Regeneron in Q1
Medical Marketing and Media
Moderna Therapeutics
Regeneron
earnings
Flag link:
Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting
BioSpace
Moderna Therapeutics
vaccines
mRNA-3927
propionic acidemia
Flag link:
The race for gold: Closing in on the first RSV vaccine
The race for gold: Closing in on the first RSV vaccine
Pharmaphorum
vaccines
RSV
GSK
Pfizer
Moderna Therapeutics
Flag link:
Second judge says US not liable in Moderna COVID-19 vaccine patent case
Second judge says US not liable in Moderna COVID-19 vaccine patent case
Reuters
Moderna Therapeutics
patents
intellectual property
legal
vaccines
COVID-19
Flag link:
Is Moderna Setting Expectations Too High?
Is Moderna Setting Expectations Too High?
Motley Fool
Moderna Therapeutics
vaccines
RSV
COVID-19
Flag link:
Finding the big spenders beyond big pharma
Finding the big spenders beyond big pharma
EP Vantage
R&D
Amgen
Bayer
Biogen
Gilead Sciences
Merck KGaA
Moderna Therapeutics
Novo Nordisk
Regeneron Pharmaceuticals
UCB
Vertex Pharmaceuticals
Flag link:
Moderna and Merck’s mRNA Cancer Vaccine Impresses but Experts Urge Caution
Moderna and Merck’s mRNA Cancer Vaccine Impresses but Experts Urge Caution
BioSpace
Moderna Therapeutics
Merck
MRNA
cancer vaccines
vaccines
Flag link:
Big pharma holds steady on research spending
Big pharma holds steady on research spending
EP Vantage
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
Flag link:
Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
BioSpace
Moderna Therapeutics
IBM
artificial intelligence
quantum computing
Flag link:
Where Will Moderna Be in 1 Year?
Where Will Moderna Be in 1 Year?
Motley Fool
Moderna Therapeutics
MRNA
vaccines
COVID-19
RSV
CMV
Flag link:

Pages